Welcome to The Body PRO Newsletter, a bi-weekly review of the latest breaking news and research in HIV medicine, aimed specifically at informing health care professionals.

April 20, 2011

In This Newsletter:

  HIV CARE TODAY

HIV Care Today is a multi-author blog featuring people on the frontlines of HIV treatment, prevention and patient/client care. This blog serves as a platform for health care professionals to discuss the everyday challenges of their jobs, recent developments in their fields and issues relevant to the evolution of HIV/AIDS care.


Paul SaxPaul Sax: Even When You Think You Should Wait, It's Probably Time to Start
Paul Sax, M.D., a member of the D.H.H.S. adult HIV treatment guidelines panel, ponders whether some recent counter-intuitive study findings should prompt us to move the "when to start" dial even earlier than it is now.


Bethsheba JohnsonBethsheba Johnson: Tips From the Frontlines on Providing the Best Possible HIV Care for Women
Bethsheba Johnson, G.N.P.-B.C., A.A.H.I.V.S., shares tips from other frontline HIV care providers on how to increase the depth and quality of care that female patients receive.


More Headlines on HIV Treatment & Complications:


  Back to Top



  HIV TREATMENT & COMPLICATIONS

Early Results Promising for BMS-663068, Potential First-in-Class Oral HIV Attachment Inhibitor
More than three years after its approval, maraviroc (Selzentry, Celsentri) remains the only HIV entry inhibitor on the market. But another candidate in development may support once-daily dosing and would not require the same expensive tropism test that maraviroc currently requires.


Study Finds Treatment Failure 40% More Common Among African Americans
A large examination of U.S. studies suggests that African Americans with HIV are much more likely than their white counterparts to experience virologic failure on their antiretroviral regimen.


face with lipoatrophyAdvocates Issue Call to Remove Barriers to Lipoatrophy Treatment Access
Medicare covers facial filler treatments for HIV-infected people with lipoatrophy, but at present it barely even matters due to inadequate reimbursements, argues AIDS advocate and treatment educator Nelson Vergel.


Vitamin D Supplementation May Offset Tenofovir-Related Increases in Parathyroid Hormone Levels
Increases in parathyroid hormone (PTH) appear to occur in young HIV-infected adults taking tenofovir (Viread) regardless of their level of vitamin D deficiency, but vitamin D supplementation may nonetheless decrease PTH levels in these individuals.


More Headlines on HIV Treatment & Complications:


  Back to Top



  HIV NEWS & VIEWS

Khafre AbifKhafre Abif: Honoring Mark Colomb, Ph.D.
"Mark A. Colomb was a staunch warrior and activist whose passion and commitment to Mississippi, the [U.S.] South and particular focus on responding to the needs of black men who have sex with men (MSM) have left a legacy of leadership," Khafre Abif writes.


Rev. Edwin SandersAfrican-American Church in Tennessee Serves as Example of How Churches Can Fight HIV
Many black clergy have been slow to meet their responsibilities in the U.S.'s fight against HIV. But not Rev. Edwin Sanders, whose church in Nashville, Tenn., houses a primary care clinic that provides HIV testing, treatment and prevention.


HIV, Music to Your Ears (Literally!)
Alexandra Pajak carefully studied HIV's genetic structure and assigned musical pitches to each individual DNA strand. The result of her work: a 17-track, 52-minute symphony entitled Sounds of HIV.


More News Headlines:


  Back to Top



  THE PATIENT PERSPECTIVE: FEATURED ON THEBODY.COM

Brandon Lacy CamposBrandon Lacy Campos: Fraud, Forgiveness, and F***ery
Though he's been living with HIV for years, Brandon Lacy Campos still struggles to be as open about his HIV status as he is about other aspects of his life, including his recovery from crystal meth addiction.


Brooke DavidoffBrooke Davidoff: A Year So Rough, Even Depression Is Hard to Feel
Brooke Davidoff's HIV diagnosis was just one of many earth-shattering events over the past 12 extremely difficult months. In her latest blog entry, Brooke can't help but ask: Am I depressed? If I were, could I even feel it?


Damaries CruzDamaries Cruz: Deciding to Start Treatment After Nearly 20 Years of Living With HIV
Damaries Cruz thought she was doing all right after 17 years of living with HIV, despite never taking antiretrovirals. Then she developed pneumonia, and the wheels came off.


quillPoetry Month at TheBody.com: HIV-Affected Readers Submit Their Work
To mark National Poetry Month in the U.S., we're posting our readers' poetry submissions about living with, or being affected by, HIV/AIDS. Take a look at the poems we've posted thus far, and encourage your patients or clients to express themselves by submitting their own pieces!


  Back to Top



  HIV/STD TRANSMISSION

PrEP Ineffective for Women? Study on Truvada for HIV Prevention Is Unexpectedly Cut Short
A clinical trial investigating the use of pre-exposure prophylaxis (PrEP) to prevent HIV infection among women has been canceled after early results suggested that, surprisingly, the approach would be ineffective.


Addressing Historical Trauma: The Struggle of Native-American Women Against HIV/AIDS
"Many Native women have a lower status economically, educationally and socially," writes the U.S. National Native American AIDS Prevention Center in this overview. "The shift has put Native women at greater risk for HIV infection."


More Headlines on HIV/STD Transmission:


  Back to Top


Advertisement



Also Worth Noting

Top HIV/AIDS Clinical Developments of 2010

David Wohl, M.D.

Of the hundreds of published studies, presented research and other major developments in HIV this year, which are the most likely to change the way we approach HIV prevention or the care of our HIV-infected patients?

In one of our most popular annual updates (available this year on TheBody.com), David Wohl, M.D., takes an in-depth look at the highlights of 2010 and their clinical implications.

HIV Management Today

In HIV Management Today, an informative online series from TheBodyPRO.com, we consult with some of the top clinical minds in HIV on some of the most important issues in HIV/AIDS clinical management.

•  Assessing and Acting on Cardiovascular Disease Risk in HIV-Infected Patients, featuring Marshall Glesby, M.D., Ph.D., and Jens Lundgren, M.D.

•  A Closer Look at Tesamorelin (Egrifta), a Newly Approved Treatment for HIV-Associated Lipohypertrophy, featuring Daniel Berger, M.D.

•  New Paradigms of First-Line HIV Therapy: Determining When (and With What) to Start, featuring Eric Daar, M.D., and Trevor Hawkins, M.D.

•  Clinical Management of the HIV-Infected Woman, featuring Kimberly Smith, M.D., M.P.H., and Valerie Stone, M.D., M.P.H.